Stradling Counsels Ligand Pharma in $3 Million Investment in Dianomi Therapeutics

Stradling advised Ligand Pharmaceuticals Inc., a San Diego-based biopharmaceutical company, in its investment in Dianomi Therapeutics Inc. Ligand announced the deal closed Feb. 5. Dianomi is a biopharmaceutical company in Madison, Wisconsin that aims to improve treatments for many diseases. The company also aims to boost therapies for inflammatory conditions, such as osteoarthritis and pain.